Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome-Reference-Cited by-同舟云学术

Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome

Published:2020-12 Issue:6 Volume:98 Page:1449-1460
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Molina-Jijon Eduardo,Gambut Stéphanie,Macé Camille,Avila-Casado Carmen,Clement Lionel C.

Funder

American Heart Association

National Institutes of Health

Publisher

Elsevier BV

Subject

Nephrology

Reference38 articles.

1. New insights into human minimal change disease: lessons from animal models;Chugh;Am J Kidney Dis,2012

2. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome;Clement;Nat Med,2014

3. Isolation, purification, and characterization of gamma-lipotropic hormone from sheep pituitary glands;Chrétien;Can J Biochem,1967

4. Insulin biosynthesis: evidence for a precursor;Steiner;Science,1967

5. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation;Seidah;Proc Natl Acad Sci U S A,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Hormone Receptor and PCSK9 Define a New Paradigm in the Initiation and Development of Chronic Kidney Disease as Revealed by Exome Sequencing on Illumina Platform;European Journal of Medical and Health Sciences;2024-01-03

2. “Idiopathic” minimal change nephrotic syndrome: a podocyte mystery nears the end;American Journal of Physiology-Renal Physiology;2023-12-01

3. Proprotein convertase subtilisin/kexin type 9 targets megalin in the kidney proximal tubule and aggravates proteinuria in nephrotic syndrome;Kidney International;2023-10

4. Targeting PCSK9 to tackle cardiovascular disease;Pharmacology & Therapeutics;2023-09

5. Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Podocytes in Mouse Nephrotic Syndrome;Laboratory Investigation;2023-09